Sounds amazing... It just keeps getting better everyday....
Fireman Rob said
Nov 11, 2014
Okay so I'm kicking myself because I read an awesome article this morning about Gilead's new Triple (6 week regimen) and can't find it now.
The nuts and bolts were that Gilead is in the early clinical stages to test Harvoni combined with another drug called "Vedroprevir" and a small sample of patients (20) at F3 (30%) which were all cured after six weeks were tested.
It looks like Vedroprevir is made by another company so a buyout may be in the works? It also said 70% of patients tested were Genotype 1a. The article also had a projected cost of about $60k for this triple assuming it makes it through FDA approval?
Has anyone else seen this? I'll keep looking. Exciting developments!
Sounds amazing... It just keeps getting better everyday....
Okay so I'm kicking myself because I read an awesome article this morning about Gilead's new Triple (6 week regimen) and can't find it now.
The nuts and bolts were that Gilead is in the early clinical stages to test Harvoni combined with another drug called "Vedroprevir" and a small sample of patients (20) at F3 (30%) which were all cured after six weeks were tested.
It looks like Vedroprevir is made by another company so a buyout may be in the works? It also said 70% of patients tested were Genotype 1a. The article also had a projected cost of about $60k for this triple assuming it makes it through FDA approval?
Has anyone else seen this? I'll keep looking. Exciting developments!
-Rob